Q&A With Dr Chao: Oncotype DX Breast Recurrence Score® and Breast DCIS Score™
CTA spoke with Calvin Chao, MD, about how the Oncotype DX® test is implemented, how results can guide treatment, its use globally, and the future of prognostic testing.
Debra Hughes, MS
Debra (Lumpe) Hughes has more than 3 decades of oncology medical writing and editing experience, including as a former editor of Oncology Times. She has a diverse background in medical journalism, education, and publishing. Her company, D.A. Hughes & Associates, provides medical communications services for academic institutions, communications and publishing companies, global pharmaceutical and biotechnology corporations, and professional medical associations and societies. Debra is an alumna of Columbia University Graduate School of Journalism, where she specialized in science writing, and the University of California, Riverside.
